107 results
Page 2 of 6
424B5
dt0c60cbd45t24t mt
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.1
fvqtpceax
26 May 21
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing
10:17am
8-K
EX-99.1
m7n478nocton qfh
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K/A
EX-99.2
02c r1n1hq5
26 Jun 20
Other Events
5:08pm